Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy

Autor: Maria Laura Canale, Domenico Amoroso, Nicola Maurea, Jacopo Del Meglio, Iris Parrini, Giancarlo Casolo, Irma Bisceglia, Chiara Lestuzzi, Alessio Lilli, Cheti Puccetti, Andrea Camerini, Lara Camerini

Publikováno v: Advances in Therapy

Introduction Cardiovascular toxicity of immunotherapy represents an underreported but potentially fatal side effect. A relatively high incidence of pericardial disease has been noticed in patients with non-small cell lung cancer (NSCLC). Methods We r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::772e2587bbc1e96f4ac8d7f1c9a278e1
https://doi.org/10.1007/s12325-020-01386-y

European Guide on Quality Improvement in Comprehensive Cancer Control

Autor: Tit, Albreht, Camilla, Amati, Angela, Angelastro, Marco, Asioli, Gianni, Amunni, Ana Molina Barceló, Christine, Berling, Augusto, Caraceni, Vittoria, Colamesta, Keith, Comiskey, Fiona, Conroy, Mary, Hynes, Maeve, Cusack, Lois, O’Connor, Daniela, D’Angelo, Ladislav, Dusek, Stein, Kaasa, Christoph, Kowalski, Yulan, Lin, Antonio, Federici, Loupakis, Fotios, Giuseppe La Torre, Lucio, Luzzatto, Ondrej, Majiek, Giovanni, Nicoletti, Pasqualetti, Giuseppe, Rosana Peiró Pérez, Alessandra, Pigni, Cheti, Puccetti, Rossi, ELIO GIOVANNI, Milena, Sant, Julien, Tognetti, Annalisa Trama and Simone Wesselmann

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3728::55dd07f13f4486d62f63d3468a8c250f
http://hdl.handle.net/11568/915625

Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)

Autor: Domenico Amoroso, Maria Cristina Petrella, S. Donati, Paolo Puccinelli, Andrea Camerini, G. Tartarelli, Cheti Puccetti, Chiara Valsuani

Publikováno v: BMC Cancer

Background Metronomic oral vinorelbine could be a safe option for elderly patients with advanced non small cell lung cancer (NSCLC). Metronomic administration of chemotherapy leads to a cytostatic action shifting treatment target from cancer cell to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1644ace7edc1a06636d59df2f20aedf0
https://doi.org/10.1186/s12885-015-1354-2

Evaluation of HER2 and p53 expression in predicting response to docetaxel-based first-line chemotherapy in advanced breast cancer

Autor: G. Tartarelli, Paolo Viacava, Chiara Valsuani, Domenico Amoroso, Leonardo Martini, Andrea Camerini, O. Siclari, Andrea Cavazzana, Filomena De Luca, Cheti Puccetti, Sara Donati

Publikováno v: Journal of Experimental & Clinical Cancer Research, Vol 30, Iss 1, p 38 (2011)
Journal of Experimental & Clinical Cancer Research : CR

Background The human epidermal growth factor receptor 2 (HER2) and p53 pathways may be involved in chemotherapy sensitivity and/or resistance. We explore the value of HER2 and p53 status to foretell docetaxel sensitivity in advanced breast cancer. Me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f866dbdecf4054dcd5f239a7a6035d20
http://www.jeccr.com/content/30/1/38

Phase II trial of single-agent oral vinorelbine in elderly (or =70 years) patients with advanced non-small-cell lung cancer and poor performance status

Autor: P. Puccinelli, C. Valsuani, M. Rondini, Domenico Amoroso, Andrea Camerini, Cheti Puccetti, G. Tartarelli, O. Siclari, F. Di Costanzo, S. Donati, Francesca Mazzoni

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 21(6)

Background Elderly patients with advanced non-small-cell lung cancer (NSCLC) with poor performance status (PS) are a special population requiring particular attention. Single-agent oral vinorelbine could be an attractive option. Patients and methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa82992323d37200b758c329e605e873
https://pubmed.ncbi.nlm.nih.gov/19914959